美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arch Therapeutics, Inc.

0.1608

0.0000

成交量：- -

成交額：- -

市值：71.47萬

市盈率：-0.07

高：0.1608

開：0.1608

低：0.1608

收：0.1608

52周最高：0.2488

52周最低：0.1573

股本：444.44萬

流通股本：429.72萬

量比：0.03

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.3462

每股收益(LYR):-2.2715

淨資產收益率：-4014.80%

總資產收益率：-199.27%

市淨率：-0.06

市盈率(LYR):-0.07

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Arch Therapeutics, Inc.

交易所：

EXPERT

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.archtherapeutics.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Arch Therapeutics, Inc.於2009年9月16日根據內華達州法律成立。該公司是一家生物技術公司，營銷和開發了許多基於創新的AC5自組裝技術平台的產品。該公司相信，這些產品可能是止血和屏障應用領域的重要進展，這些應用包括管理手術、創傷、介入治療或疾病期間產生的傷口、止血（止血）和控制滲漏（密封劑）。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ARTH/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"ARTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTH\",,,,,undefined,":{"symbol":"ARTH","market":"US","secType":"STK","nameCN":"Arch Therapeutics, Inc.","latestPrice":0.1608,"timestamp":1772830800000,"preClose":0.1608,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":4297158,"shares":4444400,"eps":-2.346175,"marketStatus":"休市中","change":0,"latestTime":"03-06 16:00:00 EST 延時","open":0.1608,"high":0.1608,"low":0.1608,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-2.346175,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1773043200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.1608,"volumeRatio":0.028958359685171516},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTH\",,,,,undefined,":{"symbol":"ARTH","floatShares":4297158,"roa":"-199.27%","roe":"-4014.80%","lyrEps":-2.271494,"volumeRatio":0.028958359685171516,"shares":4444400,"dividePrice":0,"high":0.1608,"amplitude":0,"preClose":0.1608,"low":0.1608,"week52Low":0.1573,"pbRate":"-0.06","psRate":"4.82","week52High":0.2488,"institutionHeld":0,"latestPrice":0.1608,"eps":-2.346175,"divideRate":0,"volume":0,"delay":15,"ttmEps":-2.346175,"open":0.1608,"prevYearClose":0.1608,"prevWeekClose":0.1608,"prevMonthClose":0.1608,"prevQuarterClose":0.1608,"fiveDayClose":0.1608,"twentyDayClose":0.1608,"sixtyDayClose":0.1608},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-19","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1724040000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-09","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-02-20","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1708405200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-08-11","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1691726400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-01-18","symbol":"ARTH","defaultRemindTime":1674052200000,"type":"split","dateTimestamp":1674018000000,"forFactor":200,"toFactor":1,"ratio":200}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARTH\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.archtherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":-0.1321},{"period":"3month","weight":-0.2698},{"period":"6month","weight":-0.3784},{"period":"1year","weight":-0.3867},{"period":"ytd","weight":-0.566}],"description":"Arch Therapeutics, Inc.於2009年9月16日根據內華達州法律成立。該公司是一家生物技術公司，營銷和開發了許多基於創新的AC5自組裝技術平台的產品。該公司相信，這些產品可能是止血和屏障應用領域的重要進展，這些應用包括管理手術、創傷、介入治療或疾病期間產生的傷口、止血（止血）和控制滲漏（密封劑）。","exchange":"EXPERT","name":"Arch Therapeutics, Inc.","nameEN":"Arch Therapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ARTH\",market:\"US\",,,undefined,":null}}